OVUM Voices
Longevity meets healthtech capital
All perspectives
LongevityInvestor POV·Jun 20, 2026
"Longevity healthtech is the fastest-growing capital pool in women's health-adjacent biotech."
— OVUM Editorial on LinkedIn
OVUM context
Confirms the biotech-pharma capital rotation. Watch cross-over funds enter Series B rounds in Q3.
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.